Notably, both have their own checkpoint drugs. But unlike Pfizer’s Bavencio, AstraZeneca’s Imfinzi is actually approved in China for unresectable non-small cell lung cancer. And in toripalimab, the British drugmaker is scoring a more mature drug that earned …
See Original Article
STOCKHOLM (Reuters) – Swedish payments firm Klarna has nearly tripled its valuation to $31 billion in less than six months with a new $1 billion private fundraising round, the company said on Monday. Slideshow ( 2 images ). The new round, which was …
See Original Article
Sign up for Next China, a weekly email on where the nation stands now and where it’s going next. China’s Inner Mongolia has banned cryptocurrency mining and declared it will shut all such projects by April, spurring fears the world’s No. 2 economy will take …
See Original Article
The company said it plans to use the proceeds from the offering for general corporate purposes. Based on Friday’s stock closing price of $93.27, the offering could represent about 16.08 million shares, or about 6.8% of the shares outstanding.
See Original Article
agamama owner The Restaurant Group revealed on Monday that it is burning through £5.5 million a month in lockdown as the firm announced it has secured new financing to see it through the pandemic. TRG, which is also behind the Frankie and Benny’s …
See Original Article